NCT06053138View on ClinicalTrials.gov

Assessment of BHB Concentration Agreement Among Sampling Locations and the Impact of Ketosis on EPO, and More

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

August 30, 2024

Conditions
Ketosis
Interventions
DIETARY_SUPPLEMENT

Ketone monoester

Supraphysiological levels of ketosis acutely, part 1, and intermittently and longer lasting, part 2, as obtained by ingestion of a ketone monoester dietary supplement

DIETARY_SUPPLEMENT

Placebo

The placebo vehicle is matched to the ketosis intervention in the experimental arm with regards to taste, volume, viscosity, appearence, and packaging

Trial Locations (1)

8800

Department of Internal Medicine, Viborg Regional Hospital, Viborg

All Listed Sponsors
lead

Central Jutland Regional Hospital

OTHER

NCT06053138 - Assessment of BHB Concentration Agreement Among Sampling Locations and the Impact of Ketosis on EPO, and More | Biotech Hunter | Biotech Hunter